Webinar

Research in Motion with ioSkeletal Myocytes™

Introducing human iPSC-derived muscle cells for research and drug discovery.
Research in Motion with ioSkeletal Myocytes™

Dr Luke Flatt | Senior Scientist
Charles River 

Research in Motion with ioSkeletal Myocytes™
Introducing human iPSC-derived muscle cells for research and drug discovery.
Research in Motion with ioSkeletal Myocytes™

Dr Luke Flatt | Senior Scientist
Charles River 

Dr Will Bernard, Senior Scientist at bit.bio, and Dr Luke Flatt, Senior Scientist at Charles River Laboratories discuss how bit.bio’s iPSC-derived ioSkeletal Myocytes can facilitate high-throughput screening (HTS) workflows and accelerate research into muscle and metabolic disease.

This webinar discusses how bit.bio’s iPSC-derived ioSkeletal Myocytes can facilitate HTS workflows and accelerate research into muscle and metabolic disease. 

Learning outcomes:

  • How highly-defined and characterised muscle cells can provide physiological relevance earlier in your research and drug development pipeline.
  • The potential of ioSkeletal Myocytes as a relevant translational model for research of muscle, neuromuscular and associated metabolic disorders.
  • How human induced skeletal myocytes have been generated by opti-ox™ cellular reprogramming to offer consistency at scale, easy culture and rapid maturity.

2020

Dr Luke Flatt | Senior Scientist | Charles River Laboratories

Dr Will Bernard | Senior Scientist | bit.bio

Watch webinar

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell identity coding platform behind our cells
Join us Explore the latest roles at bit.bio